COMMUNIQUÉS West-GlobeNewswire

Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
17/08/2026
Combined company to operate as Slate Medicines and focus on advancing Slate's portfolio of next-generation migraine therapeutics Slate’s lead product candidate, SLTE-1009, is a clinical stage, potentially best-in-class [...]
SEED Therapeutics Nominated for 2026 Prix Galien USA “Best Start-Up” Award
17/08/2026
Second Consecutive Nomination Recognizes SEED’s Progress in Rational Molecular Glue Development and Targeted Protein Degradation Recognition Follows First-in-Human Proof of Mechanism for Lead RBM39 Degrader ST-01156 in [...]
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
17/08/2026
Dividend to be Paid Consistent with the Company's Cash Dividend Policy REHOVOT, Israel and HOBOKEN, N.J., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company [...]
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
17/08/2026
Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon receptor (“Ahr”) agonist in development for ulcerative colitis, to its pipeline Closed initial $32 [...]
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
17/08/2026
Launch connects Tilray Medical’s European cultivation and pharmaceutical manufacturing capabilities with Lyphe Clinic and Lyphe Dispensary to expand direct patient access across the UK and advance Tilray’s integrated [...]
Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101
17/08/2026
Independent Data Monitoring Committee (IDMC) recommends recruitment of the next two patients at the first dose level First patient completed the planned first treatment cycle with no serious adverse events or dose- [...]
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
17/08/2026
Beloved Long Island craft beer brand opens its second taproom, bringing fresh brews, beach-town energy and Montauk’s come-as-you-are spirit to Port Jefferson MONTAUK, N.Y., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Montauk [...]
Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
17/08/2026
RAD 101 Phase 2b trial demonstrated 93% concordance with MRI across all evaluable lesions, meeting the Phase 2 trial's primary endpoint End-of-Phase 2 meeting with the U.S. FDA scheduled for October 1 st , 2026; on [...]
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
17/08/2026
Company’s proprietary platform brings clinical decision support and evidence-based pathways into one streamlined oncology workflow CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ: [...]
UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC
17/08/2026
PRINCETON, N.J., Aug. 17, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
17/08/2026
SAN JOSE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in [...]
NEXGEL Reports Second Quarter 2026 Financial Results
17/08/2026
LANGHORNE, Pa., Aug. 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high- [...]
Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
17/08/2026
D ifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth HOUSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company [...]
Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
17/08/2026
BOSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
17/08/2026
Launches VoteAnavex.com to Provide Additional Information on Anavex’s Director Nominees and How to Vote at the Annual Meeting of Stockholders NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“ [...]
Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
17/08/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its [...]
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
17/08/2026
EVX-05 is an off-the-shelf therapeutic glioblastoma (brain cancer) vaccine designed based on patient tumor samples. It targets novel conserved antigens identified using Evaxion’s AI-Immunology™ platform Glioblastoma is [...]
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
17/08/2026
Appointed Pharma Industry Veteran Brendan O’Grady as Chief Executive Officer Company on Track to Advance Clinical Programs to Key Second Half 2026 Milestones TEL AVIV, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nasus [...]
Novo Nordisk A/S - share repurchase programme
17/08/2026
Bagsværd, Denmark, 17 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]

Pages